26 August 2020 – MPA Webinar Series

Event #1 – Wed 26th August from 7pm to 830pm Topics: Dermatology and Melanoma Surgery Please register via the Eventbrite link: https://www.eventbrite.com.au/e/dermatology-and-melanoma-surgery-a-discussion-with-our-specialists-registration-116189932215?aff=ebdssbeac >> DOWNLOAD PDF for full details

Reminder – Melanoma Consumer Breakfast this Saturday 6th October 2108

Sat 6th October 2018, 8:00-9:30am All members of the melanoma community are invited to attend a Melanoma Consumer Breakfast. The Breakfast is part of the Australasian Melanoma Conference – which also has great consumer forums. The program is on the website. All bookings can be made via the conference website http://australasianmelanoma.org/

Melanoma survivors march to honour lost friends and raise awareness

Melanoma has a reputation for being one of the most curable types of cancers, but that does not mean much to survivors such as Jay Allen and Aaron Kelly.

Free skin checks for South West community

The Bunbury Skin Cancer Clinic is partnering with melanomaWA to provide the community with free skin checks on February 24.

Cancer in the News

Feature Articles

LAG-3 Antibody Relatlimab Combined With PD-1 Inhibition Improves PFS in Previously Untreated Melanoma

The randomized, double-blind phase 2/3 RELATIVITY-047 trial (NCT03470922) examining the experimental anti–LAG-3 antibody relatlimab plus nivolumab (Opdivo) versus nivolumab alone in patients with treatment-naïve metastatic or unresectable melanoma met its primary end point of progression-free survival, according to Bristol Myers Squibb who is responsible for developing the agent.1

READ MORE >

Posted in Melanoma News, Health Professionals, Clinical Trials

Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation

In fifteen patients with stage 0–III melanoma, the numbers of CTCs were analyzed.

READ MORE >

Posted in Melanoma News, Publications, Scientific Publications

Forty-three percent of melanoma patients have chronic complications from immunotherapies

Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than previously recognized, according to a study published March 25 in JAMA Oncology.

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest

Combos Lead Excitement in BRAF+ Melanoma, but More Pain Points are Ready to be Tackled

Therapeutic approaches to target the metabolic pathways, an enhanced understanding of how to utilize triplet regimens, and improving outcomes for patients with brain metastases are all areas being tackled in the setting of advanced BRAF-positive melanoma, explained Michael A. Davies, MD, PhD.

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest